Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Safety and Efficacy Trial of Chlorhexidine and/or Metronidazole Pre-treatment Followed by FB301 in Women With Bacterial Vaginosis

NCT07481955 is registered in ClinicalTrials.gov with Freya Biosciences ApS as lead sponsor.

NCT NCT07481955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07481955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Safety and Efficacy Trial of Chlorhexidine and/or Metronidazole Pre-treatment Followed by FB301 in Women With Bacterial Vaginosis
Lead sponsor
Freya Biosciences ApS
Phase
Phase 2
Overall status
Recruiting
Start date
March 23, 2026
Completion date
April 21, 2027
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis (bv)